The clinical relevance of adiposity when assessing muscle health in men treated with androgen deprivation for prostate cancer.
Patrick J OwenRobin M DalyJack Dalla ViaNiamh L MundellPatricia M LivingstonTimo RantalainenSteve F FraserPublished in: Journal of cachexia, sarcopenia and muscle (2019)
The findings from this study indicate muscle mass, size, and strength are compromised in men treated with ADT after accounting for their increased adiposity or body size.